Novel Analogues of CC-1065 and the Duocarmycins for the Use in Targeted Tumour Therapies

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|9|3|304-325

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.3, 2009-01, pp. : 304-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Targeted Therapies and Vaccination Strategies for Mesothelioma

By Bagia Mamta  

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 149-162

Springer Publishing Company

Access to resources Recommend Favorite

Locoregional Therapies of Liver Metastases in a Rat CC531 Coloncarcinoma Model Results in Increased Resistance to Tumour Rechallenge

By Duijnhoven F.H.   Tollenaar R.A.E.M.   Terpstra O.T.   Kuppen P.J.K.  

Clinical and Experimental Metastasis, Vol. 22, Iss. 3, 2005-05 ,pp. : 247-253

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Trials of Novel and Targeted Therapies: Endpoints, Trial Design, and Analysis

By Suman Vera   Dueck Amylou   Sargent Daniel  

Cancer Investigation, Vol. 26, Iss. 5, 2008-06 ,pp. : 439-444

Informa Healthcare

Access to resources Recommend Favorite

Targeted therapies in bronchioloalveolar carcinoma

By Scagliotti Giorgio  

Targeted Oncology, Vol. 3, Iss. 3, 2008-07 ,pp. : 197-204

Springer Publishing Company

Access to resources Recommend Favorite

Cell-cycle targeted therapies

By Swanton C.  

Lancet Oncology, Vol. 5, Iss. 1, 2004-01 ,pp. : 27-36

Elsevier

Access to resources Recommend Favorite